Genetic polymorphisms of hemostatic factors and thrombotic risk in non BCR -ABL myeloproliferative neoplasms: A pilot study
, , , , , , , und
30. Juni 2017
Über diesen Artikel
Artikel-Kategorie: Original Article
Online veröffentlicht: 30. Juni 2017
Seitenbereich: 35 - 42
DOI: https://doi.org/10.1515/bjmg-2017-0005
Schlüsselwörter
© 2017 Dambrauskienė R, Gerbutavičius R, Ugenskienė R, Jankauskaitė R, Savukaitytė A, Šimoliūnienė R, Rudžianskienė M, Gerbutavičienė R, Juozaitytė E
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Dambrauskienė, R
Department of Oncology and Hematology, Institute of Oncology, Lithuanian University of Health SciencesKaunas, Lithuania
Gerbutavičius, R
Department of Oncology and Hematology, Institute of Oncology, Lithuanian University of Health SciencesKaunas, Lithuania
Ugenskienė, R
Lithuanian University of Health Sciences, Institute of Oncology, Oncology Research LaboratoryKaunas, Lithuania
Jankauskaitė, R
Lithuanian University of Health Sciences, Institute of Oncology, Oncology Research LaboratoryKaunas, Lithuania
Savukaitytė, A
Lithuanian University of Health Sciences, Institute of Oncology, Oncology Research LaboratoryKaunas, Lithuania
Šimoliūnienė, R
Department of Physics, Mathematics and Biophysics, Lithuanian University of Health SciencesKaunas, Lithuania
Rudžianskienė, M
Department of Oncology and Hematology, Institute of Oncology, Lithuanian University of Health SciencesKaunas, Lithuania
Gerbutavičienė, R
Department of Drug Technology and Social Pharmacy, Faculty of Pharmacy, Lithuanian University of Health SciencesKaunas, Lithuania
Juozaitytė, E
Department of Oncology and Hematology, Institute of Oncology, Lithuanian University of Health SciencesKaunas, Lithuania